Recursion Pharmaceuticals uses AI to improve the process of discovering and developing drugs, making it easier and more cost ...
The latest chemistry news, including important research advances, business and policy trends, chemical safety practices, career ...
Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates ...
After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the ...
Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results